The European Unions' clinical trials directive

Journal of the Royal Society of Medicine

Volumn 94, Issue 11, 2001, Pages 557-558

  Slater, A E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DECISION MAKING; DRUG EFFICACY; DRUG LEGISLATION; DRUG QUALITY; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; EUROPEAN UNION; HUMAN; MEDICINAL PLANT; STANDARD;

EID: 0035172288     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107680109401101     Document Type: Editorial

References (9)

1. On the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
2. EU Directive on clinical trials will cost lives
3. New directive for clinical research will have huge impact on pharmacists
4. Red tape threatens research
5. New rules might hinder research
6. Co-ordination of public funding for European Clinical Trials
7. Harmonisation of clinical trials: Administrative constraints
8. Implications of the new clinical trials directive